A simple Chinese risk score model for screening cardiovascular autonomic neuropathy.

BACKGROUND: The purpose of the present study was to develop and evaluate a risk score to predict people at high risk of cardiovascular autonomic dysfunction neuropathy (CAN) in Chinese population. METHODS AND MATERIALS: A population-based sample of 2,092 individuals aged 30-80 years, without previou...

Full description

Bibliographic Details
Main Authors: Xiaoli Ge, Shu-Ming Pan, Fangfang Zeng, Zi-Hui Tang, Ying-Wei Wang
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3951191?pdf=render
id doaj-4f01aa8050c94429b29a527ddff14e75
record_format Article
spelling doaj-4f01aa8050c94429b29a527ddff14e752020-11-24T21:50:43ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0193e8962310.1371/journal.pone.0089623A simple Chinese risk score model for screening cardiovascular autonomic neuropathy.Xiaoli GeShu-Ming PanFangfang ZengZi-Hui TangYing-Wei WangBACKGROUND: The purpose of the present study was to develop and evaluate a risk score to predict people at high risk of cardiovascular autonomic dysfunction neuropathy (CAN) in Chinese population. METHODS AND MATERIALS: A population-based sample of 2,092 individuals aged 30-80 years, without previously diagnosed CAN, was surveyed between 2011 and 2012. All participants underwent short-term HRV test. The risk score was derived from an exploratory set. The risk score was developed by stepwise backward multiple logistic regression. The coefficients from this model were transformed into components of a CAN score. This score was tested in a validation and entire sample. RESULTS: The final risk score included age, body mass index, hypertension, resting hear rate, items independently and significantly (P<0.05) associated with the presence of previously undiagnosed CAN. The area under the receiver operating curve was 0.726 (95% CI 0.686-0.766) for exploratory set, 0.784 (95% CI 0.749-0.818) for validation set, and 0.756 (95% CI 0.729-0.782) for entire sample. In validation set, at optimal cutoff score of 5 of 10, the risk score system has the sensitivity, specificity, and percentage that needed subsequent testing were 69, 78, and 30%, respectively. CONCLUSION: We developed a CAN risk score system based on a set of variables not requiring laboratory tests. The score system is simple fast, inexpensive, noninvasive, and reliable tool that can be applied to early intervention to delay or prevent the disease in China.http://europepmc.org/articles/PMC3951191?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Xiaoli Ge
Shu-Ming Pan
Fangfang Zeng
Zi-Hui Tang
Ying-Wei Wang
spellingShingle Xiaoli Ge
Shu-Ming Pan
Fangfang Zeng
Zi-Hui Tang
Ying-Wei Wang
A simple Chinese risk score model for screening cardiovascular autonomic neuropathy.
PLoS ONE
author_facet Xiaoli Ge
Shu-Ming Pan
Fangfang Zeng
Zi-Hui Tang
Ying-Wei Wang
author_sort Xiaoli Ge
title A simple Chinese risk score model for screening cardiovascular autonomic neuropathy.
title_short A simple Chinese risk score model for screening cardiovascular autonomic neuropathy.
title_full A simple Chinese risk score model for screening cardiovascular autonomic neuropathy.
title_fullStr A simple Chinese risk score model for screening cardiovascular autonomic neuropathy.
title_full_unstemmed A simple Chinese risk score model for screening cardiovascular autonomic neuropathy.
title_sort simple chinese risk score model for screening cardiovascular autonomic neuropathy.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2014-01-01
description BACKGROUND: The purpose of the present study was to develop and evaluate a risk score to predict people at high risk of cardiovascular autonomic dysfunction neuropathy (CAN) in Chinese population. METHODS AND MATERIALS: A population-based sample of 2,092 individuals aged 30-80 years, without previously diagnosed CAN, was surveyed between 2011 and 2012. All participants underwent short-term HRV test. The risk score was derived from an exploratory set. The risk score was developed by stepwise backward multiple logistic regression. The coefficients from this model were transformed into components of a CAN score. This score was tested in a validation and entire sample. RESULTS: The final risk score included age, body mass index, hypertension, resting hear rate, items independently and significantly (P<0.05) associated with the presence of previously undiagnosed CAN. The area under the receiver operating curve was 0.726 (95% CI 0.686-0.766) for exploratory set, 0.784 (95% CI 0.749-0.818) for validation set, and 0.756 (95% CI 0.729-0.782) for entire sample. In validation set, at optimal cutoff score of 5 of 10, the risk score system has the sensitivity, specificity, and percentage that needed subsequent testing were 69, 78, and 30%, respectively. CONCLUSION: We developed a CAN risk score system based on a set of variables not requiring laboratory tests. The score system is simple fast, inexpensive, noninvasive, and reliable tool that can be applied to early intervention to delay or prevent the disease in China.
url http://europepmc.org/articles/PMC3951191?pdf=render
work_keys_str_mv AT xiaolige asimplechineseriskscoremodelforscreeningcardiovascularautonomicneuropathy
AT shumingpan asimplechineseriskscoremodelforscreeningcardiovascularautonomicneuropathy
AT fangfangzeng asimplechineseriskscoremodelforscreeningcardiovascularautonomicneuropathy
AT zihuitang asimplechineseriskscoremodelforscreeningcardiovascularautonomicneuropathy
AT yingweiwang asimplechineseriskscoremodelforscreeningcardiovascularautonomicneuropathy
AT xiaolige simplechineseriskscoremodelforscreeningcardiovascularautonomicneuropathy
AT shumingpan simplechineseriskscoremodelforscreeningcardiovascularautonomicneuropathy
AT fangfangzeng simplechineseriskscoremodelforscreeningcardiovascularautonomicneuropathy
AT zihuitang simplechineseriskscoremodelforscreeningcardiovascularautonomicneuropathy
AT yingweiwang simplechineseriskscoremodelforscreeningcardiovascularautonomicneuropathy
_version_ 1725882155019534336